129 related articles for article (PubMed ID: 38883837)
1. Demethylase FTO-mediated m6A modification of SIK1 modulates placental cytotrophoblast syncytialization in type 2 diabetes mellitus.
Ning J; Yan J; Wang S; Cui Z; Xue Y; Juan J; Yang H
iScience; 2024 Jun; 27(6):109900. PubMed ID: 38883837
[TBL] [Abstract][Full Text] [Related]
2. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
[TBL] [Abstract][Full Text] [Related]
3. Fear Stress During Pregnancy Affects Placental m6A-Modifying Enzyme Expression and Epigenetic Modification Levels.
Wang Q; Pan M; Zhang T; Jiang Y; Zhao P; Liu X; Gao A; Yang L; Hou J
Front Genet; 2022; 13():927615. PubMed ID: 35812725
[TBL] [Abstract][Full Text] [Related]
4. FTO protein regulates the TGF-β signalling pathway through RNA N6-methyladenosine modification to induce unexplained recurrent spontaneous abortion.
Zhang J; Liu X; Gao Y
FEBS J; 2024 Apr; 291(7):1545-1559. PubMed ID: 38245815
[TBL] [Abstract][Full Text] [Related]
5. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
6. The m6A demethylase FTO promotes keloid formation by up-regulating COL1A1.
Ren S; Ji Y; Wang M; Ye M; Huang L; Cai X
Ann Transl Med; 2023 Jan; 11(1):15. PubMed ID: 36760238
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
[TBL] [Abstract][Full Text] [Related]
8. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability.
Zou L; Chen W; Zhou X; Yang T; Luo J; Long Z; Wu J; Lv D; Mao X; Cen S
Cell Death Discov; 2022 Apr; 8(1):184. PubMed ID: 35397614
[TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion.
Xie D; Yang K; Xu Y; Li Y; Liu C; Dong Y; Chi J; Yin X
J Diabetes Complications; 2024 Jun; 38(8):108801. PubMed ID: 38935979
[TBL] [Abstract][Full Text] [Related]
11. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
[TBL] [Abstract][Full Text] [Related]
12. m6A mRNA methylation regulates the development of gestational diabetes mellitus in Han Chinese women.
Wang J; Wang K; Liu W; Cai Y; Jin H
Genomics; 2021 May; 113(3):1048-1056. PubMed ID: 33667648
[TBL] [Abstract][Full Text] [Related]
13. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress-mediated activation of FTO exacerbates impairment of the epithelial barrier by up-regulating IKBKB via N6-methyladenosine-dependent mRNA stability in asthmatic mice exposed to PM2.5.
Xiong A; He X; Liu S; Ran Q; Zhang L; Wang J; Jiang M; Niu B; Xiong Y; Li G
Ecotoxicol Environ Saf; 2024 Mar; 272():116067. PubMed ID: 38325270
[TBL] [Abstract][Full Text] [Related]
16. FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1.
Zhou C; She X; Gu C; Hu Y; Ma M; Qiu Q; Sun T; Xu X; Chen H; Zheng Z
J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37781923
[TBL] [Abstract][Full Text] [Related]
17. NR3C1/Glucocorticoid receptor activation promotes pancreatic β-cell autophagy overload in response to glucolipotoxicity.
Wu T; Shao Y; Li X; Wu T; Yu L; Liang J; Zhang Y; Wang J; Sun T; Zhu Y; Chang X; Wang S; Chen F; Han X
Autophagy; 2023 Sep; 19(9):2538-2557. PubMed ID: 37039556
[TBL] [Abstract][Full Text] [Related]
18. Increased m6A modification of RNA methylation related to the inhibition of demethylase FTO contributes to MEHP-induced Leydig cell injury
Zhao T; Wang J; Wu Y; Han L; Chen J; Wei Y; Shen L; Long C; Wu S; Wei G
Environ Pollut; 2021 Jan; 268(Pt A):115627. PubMed ID: 33010548
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Transcriptomic Profiling of m6A Modification in Age-Related Hearing Loss.
Feng M; Zhou X; Hu Y; Zhang J; Yang T; Chen Z; Yuan W
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892219
[TBL] [Abstract][Full Text] [Related]
20. The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer.
Zhao Y; Hu X; Yu H; Sun H; Zhang L; Shao C
Research (Wash D C); 2024; 7():0313. PubMed ID: 38384328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
